Drugmaker Daiichi Sankyo eyes COVID-19 vaccine clinical test in March

Japanese drugmaker Daiichi Sankyo Co. said Friday it aims to launch a clinical study of a genetic vaccine for the new coronavirus around March 2021.Daiichi Sankyo said recent testing of its prototype vaccine on animals in joint research with the Institute of Medical Sciences at the University of Tokyo showed an increase in antibodies against the coronavirus.If the clinical test is successful, it hopes to supply the vaccine "as soon as possible" in collaboration with the Minister of Health, Labor and Welfare and other partners, the drugmaker said.The vaccine it is working on contains messeng…READ FULL ARTICLE